Cooley Noted Among Finalists for Multiple GCR Awards

The work of Cooley’s antitrust & competition practice in three matters has been shortlisted as part of Global Competition Review’s annual GCR Awards series. In the Merger Control Matter of the Year – Americas category, GCR shortlisted Horizon Therapeutic’s $28 billion acquisition by Amgen, in which the firm represented Horizon. Additionally, the publication shortlisted One Medical’s $3.9 billion acquisition by Amazon, in which Cooley represented One Medical.

In the category covering Litigation of the Year – Non-Cartel Defense, the firm’s work was noted in the shortlisting of Real Estate Exchange, Inc. v. Zillow, Inc., for which the firm secured a summary judgment victory for the National Association of Realtors.

Read the full nomination list (subscription required)

The winners will be announced at GCR’s 14th annual awards ceremony on April 9 in Washington, DC.

In January 2024, GCR recommended Cooley and its partners in its GCR 100, an annual listing and analysis of the world’s top competition and antitrust law practices, for Brussels and Washington, DC.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.